Trial · NCT07893613
Effects of Chronic Exercise on Hormonal and Mineral Biomarkers in Male University Students
NCT07893613, Not applicable, Completed, High Institute of Sports and Physical Education of Kef
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Effects of Chronic Exercise on Hormonal and Mineral Biomarkers in Male University Students. Trials, record NCT07893613. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07893613
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Effects of Chronic Exercise on Hormonal and Mineral Biomarkers in Male University Students
- NCT number
- NCT07893613
- Status
- Completed
- Phases
- Not applicable
- Enrollment
- 29 participants, actual
- Lead sponsor
- High Institute of Sports and Physical Education of Kef
- Conditions
- Hormonal Response, Mineral Metabolism, Exercise Training
- Interventions
- High-intensity interval training program
- First posted
- 2026-10-26
- Last updated
- 2026-10-26
Source ClinicalTrials.gov
Registered outcomes9
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Testosterone | One day before the start and two days after the completion of the 09 weeks of training program | Testosterone concentration, expressed in µg/dL, was measured using enzyme-linked immunosorbent assay (ELISA) kits (Monobind, Inc., Lake Forest, CA). |
| Primary | Cortisol | One day before the start and two days after the completion of the 09 weeks of training program. | Cortisol concentration, expressed in µg/dL, was measured using an automated chemiluminescence immunoassay (DiaSorin Inc., Stillwater, MN). |
| Primary | Testosterone/cortisol ratio | One day before the start and two days after the completion of the 09 weeks of training program. | Testosterone/cortisol ratio (T/C) was calculated by dividing the testosterone value by the cortisol value for each participant. |
| Primary | Parathyroid Hormone | One day before the start and two days after the completion of the 09 weeks of training program. | Parathyroid hormone concentration, expressed in pg/mL, was measured using an automated chemiluminescence immunoassay (DiaSorin Inc., Stillwater, MN). |
| Primary | Growth hormone | One day before the start and two days after the completion of the 09 weeks of training program. | Growth hormone concentration, expressed in mIU/L, was measured using an immunoradiometric assay (IRMA GH; Beckman Coulter). |
| Primary | 25-hydroxyvitamin D | One day before the start and two days after the completion of the 09 weeks of training program. | 25-hydroxyvitamin D \[25(OH)D\] concentration, expressed in ng/mL, was analyzed using an automated chemiluminescence immunoassay (DiaSorin Inc., Stillwater, MN). |
| Primary | Aerobic capacity | One day before the start and two days after the completion of the 09 weeks of training program. | Aerobic capacity was assessed using the Vameval incremental running test performed to exhaustion (Cazorla, 1999). Maximal aerobic speed (MAS), expressed in km/h, was determined from the highest running speed achieved during the test, and maximal oxygen uptake (VO₂max), expressed in mL·kg-¹·min-¹, was estimated using the Vameval protocol (Cazorla, 1999). |
| Secondary | Calcium | One day before the start and two days after the completion of the 09 weeks of training program. | Calcium concentration, expressed in mg/L, was assessed on Architect C8000 analyzer (Abbott Laboratories, Abbott Park, IL), using the respective reagents kits. |
| Secondary | Phosphorus | One day before the start and two days after the completion of the 09 weeks of training program. | Phosphorus concentration, expressed in mg/L, was assessed on Architect C8000 analyzer (Abbott Laboratories, Abbott Park, IL), using the respective reagents kits. |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07893613
GET https://conductscience.org/api/trials/v1/NCT07893613/registered